Skip to content
ppharmaranks
Menu

KANJINTI vs TALZENNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. KANJINTI and TALZENNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
64/100

Pharmacy pays

Type

RX
RX

Active ingredient

TRASTUZUMAB-ANNS
TALAZOPARIB TOSYLATE

Manufacturer

Dosage forms

Injectable
Capsule

Drug class

Poly(Adp-Ribose) Polymerase Inhibitor

Boxed warning

Treats

Breast Neoplasms, Gastrointestinal Neoplasms
Breast Neoplasms

Frequently asked questions

Which is better-rated, Kanjinti or Talzenna?

By our independent rating, Kanjinti scores higher — 3.6 vs 3.2 out of 5 for Talzenna. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Kanjinti and Talzenna?

Kanjinti contains Trastuzumab-Anns, while Talzenna contains Talazoparib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.